Publication Name	World Journal of Gastrointestinal Pathophysiology
Manuscript ID	52594
Country	Australia

Received	2019-11-12 02:06
Peer-Review Started	2019-11-12 02:07
To Make the First Decision	2020-01-07 09:35
Return for Revision	2020-01-07 09:36
Revised	2020-03-04 04:32
Second Decision	2020-03-12 14:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2020-03-12 23:12
Articles in Press	2020-03-12 23:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2020-04-08 02:46
Publish the Manuscript Online	2020-04-08 09:25

ISSN	2150-5330 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Observational Study
Article Title	Outcomes of a drug shortage requiring switching in patients with ulcerative colitis
Manuscript Source	Invited Manuscript
All Author List	Daniel R van Langenberg, Richard Kai-Yuan Cheng and Mayur Garg
ORCID	Author(s) ORCID Number Daniel R van Langenberg http://orcid.org/0000-0003-3662-6307 Richard Kai-Yuan Cheng http://orcid.org/0000-0002-7286-0099 Mayur Garg http://orcid.org/0000-0002-9149-3589
Funding Agency and Grant Number
Corresponding Author	Daniel R van Langenberg, FRACP, MBBS, PhD, Associate Professor, Department of Gastroenterology, Eastern Health, 8 Arnold Street，Box Hill, Victoria 3128, Australia. daniel.van-langenberg@monash.edu
Key Words	Inflammatory bowel disease; Ulcerative colitis; Drug supply; Drug shortage; Patient outcomes; Market share
Core Tip	As a chronic disease, this study of a drug shortage in ulcerative colitis provides an excellent, novel insight into the short and long term effects of an sudden, unexpected nationwide drug shortage (in this case balsalazide) in patients previously in stable remission. The study highlights the importance of maintaining a seamless drug supply for both patients (given significant rates of disease worsening occurred, directly attributable to shortage), and drug manufacturers given the loss of market share engendered by even a short term drug shortage.
Publish Date	2020-04-08 09:25
Citation	Langenberg DR, Cheng RKY, Garg M. Outcomes of a drug shortage requiring switching in patients with ulcerative colitis. World J Gastrointest Pathophysiol 2020; 11(2): 32-42
URL	https://www.wjgnet.com/2150-5330/full/v11/i2/32.htm
DOI	https://dx.doi.org/10.4291/wjgp.v11.i2.32

Full Article (PDF)	WJGP-11-32.pdf
Full Article (Word)	WJGP-11-32.docx
STROBE Statement	52594-STROBE-Statement-revision.docx
Manuscript File	52594-Review.docx
Answering Reviewers	52594-Answering reviewers.pdf
Audio Core Tip	52594-Audio core tip.wav
Biostatistics Review Certificate	52594-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	52594-Conflict-of-interest statement.pdf
Copyright License Agreement	52594-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	52594-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	52594-Institutional review board statement.pdf
Peer-review Report	52594-Peer-review(s).pdf
Scientific Misconduct Check	52594-Scientific misconduct check.pdf
Scientific Editor Work List	52594-Scientific editor work list.pdf